Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment

Retrovirology, 05/01/2012

Here, the authors present an overview of recent data that bring to light historical overestimation of A3G's standing as a strictly anti–viral agent. They discuss the limitations of experimental systems used to assess its activities as well as caveats in data interpretation.

Print Article Summary Cat 2 CME Report